Literature DB >> 28531295

Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.

Thomas M Gorter1, Dirk J van Veldhuisen1, Adriaan A Voors1, Yoran M Hummel1, Carolyn S P Lam2, Rolf M F Berger3, Joost P van Melle1, Elke S Hoendermis1.   

Abstract

Aims: Many patients with heart failure with preserved ejection fraction (HFpEF) develop post-capillary pulmonary hypertension (PH) due to increased left-sided filling pressures. However, a subset of patients develops combined post- and pre-capillary PH. We studied the value of echocardiographic right-sided characterization for the discrimination between pre- vs. post-capillary PH in HFpEF, using invasive haemodynamics as gold standard. Methods and results: 102 consecutive HFpEF patients with simultaneous right heart catheterization and echocardiography were identified. Patients were divided into: 'no PH', 'isolated post-capillary PH', and 'post- and pre-capillary PH'. Systolic pulmonary arterial pressure (SPAP), tricuspid valve annular plane systolic excursion (TAPSE), right ventricular-vascular coupling (TAPSE/SPAP), and VO2-max were assessed. Primary endpoint was all-cause mortality. A total of 97 patients were included: 22% no PH, 47% isolated post-capillary PH, and 31% post- and pre-capillary PH. Patients with post- and pre-capillary PH had more often diabetes mellitus (47 vs. 24%, P = 0.04), had more heart failure hospitalizations (57 vs. 26%, P = 0.007) and lower VO2-max (10 vs. 13 mL/min/kg, P = 0.008), compared with those with isolated post-capillary PH. Patients with post- and pre-capillary PH also had more reduced TAPSE (17 vs. 21 mm, P = 0.001) and TAPSE/SPAP (0.3 vs. 0.5, P < 0.001). TAPSE/SPAP ratio <0.36 had a good accuracy to identify patients with additional pre-capillary PH (C-statistic 0.86, sensitivity 86% and specificity 79%). TAPSE/SPAP ratio was associated with increased mortality (HR 2.51 [95% CI 1.25-5.01], P = 0.009).
Conclusion: Abnormal right ventricular-vascular coupling identifies patients with HFpEF and additional pre-capillary PH, and predicts poor outcome in HFpEF.

Entities:  

Mesh:

Year:  2018        PMID: 28531295     DOI: 10.1093/ehjci/jex133

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  21 in total

Review 1.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

2.  Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Authors:  Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

3.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

4.  Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension.

Authors:  Evan L Brittain; Anna R Hemnes
Journal:  Circ Res       Date:  2019-08-01       Impact factor: 17.367

Review 5.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

6.  Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Sorin Pislaru; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-02-21       Impact factor: 29.983

Review 7.  Combined pre- and post-capillary pulmonary hypertension in left heart disease.

Authors:  M Riccardi; M Pagnesi; E Sciatti; C M Lombardi; R M Inciardi; M Metra; E Vizzardi
Journal:  Heart Fail Rev       Date:  2022-06-01       Impact factor: 4.214

8.  Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.

Authors:  Khodr Tello; Jun Wan; Antonia Dalmer; Rebecca Vanderpool; Hossein A Ghofrani; Robert Naeije; Fritz Roller; Emad Mohajerani; Werner Seeger; Ulrike Herberg; Natascha Sommer; Henning Gall; Manuel J Richter
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-10       Impact factor: 7.792

Review 9.  A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy.

Authors:  Ersilia M DeFilippis; Marco Guazzi; Paolo C Colombo; Melana Yuzefpolskaya
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

10.  Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart.

Authors:  Andreas J Rieth; Manuel J Richter; Khodr Tello; Henning Gall; Hossein A Ghofrani; Stefan Guth; Christoph B Wiedenroth; Werner Seeger; Steffen D Kriechbaum; Veselin Mitrovic; P Christian Schulze; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2021-06-10       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.